1,162 reports of this reaction
2.8% of all ALIROCUMAB reports
#4 most reported adverse reaction
MUSCLE SPASMS is the #4 most commonly reported adverse reaction for ALIROCUMAB, manufactured by Regeneron Pharmaceuticals, Inc.. There are 1,162 FDA adverse event reports linking ALIROCUMAB to MUSCLE SPASMS. This represents approximately 2.8% of all 42,209 adverse event reports for this drug.
Patients taking ALIROCUMAB who experience muscle spasms should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MUSCLE SPASMS is a less commonly reported adverse event for ALIROCUMAB, but still significant enough to appear in the safety profile.
In addition to muscle spasms, the following adverse reactions have been reported for ALIROCUMAB:
The following drugs have also been linked to muscle spasms in FDA adverse event reports:
MUSCLE SPASMS has been reported as an adverse event in 1,162 FDA reports for ALIROCUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.
MUSCLE SPASMS accounts for approximately 2.8% of all adverse event reports for ALIROCUMAB, making it a notable side effect.
If you experience muscle spasms while taking ALIROCUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.